US exporters suffering in Argentina
This article was originally published in Clinica
Executive Summary
US medtech exports to Argentina have fallen over 20% since 1994 to $74 million. Exporters face stiff competition from local industry and several emerging-nation exporters, says industry association HIMA. Local companies account for between 25 and 30% of the market, with the US holding a 35% share and the remainder comprising products from Germany, Japan, Brazil, Thailand and South Korea.
You may also be interested in...
Pipeline Watch: Five Approvals And 23 Phase III Updates
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
Lack Of Industry Involvement In Scoping Process Exacerbates ‘Unworkable’ Timelines
Scientific advice could help companies make up for the lack of involvement in scoping, but slots are in short supply.
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.